BioCentury
ARTICLE | Company News

Corixa, CytRx deal

April 15, 1996 7:00 AM UTC

CYTR's Vaxcel Inc. subsidiary granted Corixa worldwide exclusive rights to use the Optivax vaccine delivery and adjuvant system in Corixa's cancer and infectious disease vaccines. Corixa also has the...